Maker Leads With 20 Horses Nominated For Claiming Crown At Gulfstream

Graded stakes-placed in his most recent start, Three Diamonds Farm's Doubly Blessed is among six Mike Maker-trained nominations for the $125,000 Jewel, the centerpiece of the $810,000 nine-race Claiming Crown Dec. 4 at Gulfstream Park in Hallandale Beach, Fla.

Doubly Blessed, who finished third in the Sept. 21 Grade 2 Kelso Handicap at Belmont Park in Elmont, N.Y., is among 27 nominees for the Jewel, a 1 1/8-mile event for 3-year-olds and up who have started for a claiming price for $35,000 or less in 2020-2021. Maker, who has saddled a record 18 winners of Claiming Crown races, is also represented on the noms list by Auburn Hills, First Line, Healing, Malthael, and Mr. Tip.

Maker, who has saddled two Jewel champions, has nominated 20 horses for the Claiming Crown, the annual showcase for the blue-collar Thoroughbreds that are the day-to-day backbone of the racing industry throughout the country.

Trainer Saffie Joseph Jr. has nominated four horses for the Jewel, including John Fanelli and partners' Girolamo's Attack who most recently captured the Oct. 27 Miami Beach Handicap, and Sonata Stable's Calibrator, who most recently romped to a dominating optional claiming allowance at Gulfstream.

The Claiming Crown, which attracted a total of 267 nominations for nine starter stakes, will headline opening weekend of the 2021-2022 Championship Meet that will get underway Friday, Dec. 3.

The $95,000 Emerald, a 1 1/16-mile turf race for 3-year-olds and up who have raced for a claiming price of $25,000 or less during 2020-2021, leads all Claiming Crown races with 50 nominations, including five trained by Maker, who has saddled a record seven Emerald winners. Bruno Schickedanz's War Bomber, who captured the $125,000 Toronto Cup Sept. 12 at Woodbine Racetrack in Toronto, Ontario, in his first start after being claimed for $25,000, is also prominent on the noms list.

The $95,000 Tiara, a 1 1/16-mile turf race for fillies and mares who started for a claiming price of $25,000 or less in 2020-2021, drew 30 nominations, including Mike Repole's Kitten by the Sea, whom Hall of Fame trainer Todd Pletcher saddled for back-to-back optional claiming allowance races at Saratoga.

[Story Continues Below]

The $90,000 Distaff Dash, a five-furlong turf sprint for fillies and mares who started for a claiming price of $25,000 or less, drew 27 nominations; the $90,000 Canterbury Tom Metzen Memorial, a five-furlong turf dash for 3-year-olds and up who started for a claiming price of $25,000 or less, attracted 33 nominations; the $85,000 Rapid Transit, a seven-furlong sprint for 3-year-olds and up who ran for a $16,000 claiming price or less, got 27 nominations; the $80,000 Glass Slipper, a one-mile stakes for fillies and mares who ran for a $12,500 claiming price or less, attracted 24 nominations; the $75,000 Iron Horse Kent Stirling Memorial, a 1 1/16-mile race for 3-year-olds and up who raced for a claiming price of $9000 or less, drew 25 nominations; the $75,000 Express, a six-furlong sprint for 3-year-olds and up who have run for a claiming price of $8000 or less, received 24 nominations.

The post Maker Leads With 20 Horses Nominated For Claiming Crown At Gulfstream appeared first on Horse Racing News | Paulick Report.

Source of original post

Dechra Acquires License For Two Equine Regenerative Therapy Systems

Dechra Veterinary Products is pleased to announce the acquisition of the veterinary marketing and distribution rights to the ProVet APC™ (Autologous Platelet Concentrate) and ProVet BMC™ (Bone Marrow Concentrate) systems from Hassinger Biomedical. These two patented medical devices concentrate platelets or bone marrow in 90 seconds with a processing time of 2.5 minutes from start to finish.

The ProVet APC system is a revolutionary device and is arguably the fastest and most transportable platelet concentrator available to the veterinary industry at less than 3 pounds total weight. Some of the system features include the ability to isolate approximately 90 percent of available platelets and growth factors, delivering the highest level of reproducibility with a low 3.5 percent coefficient of variance and a 97 percent reduction in red blood cell numbers.

[Story Continues Below]

The proprietary technology found within ProVet APC consistently delivers 6 to 8mls of 7.8 times high concentration of platelet rich plasma and a healing concentrate derived from 54mls of whole blood in the 60ml system.

Mike Eldred, President of Dechra North America stated, “The medical industry has long recognized that harnessing the growth factors found in platelets positively enhances healing results and reduces recovery time in soft tissue injuries. These two products will be great additions to our equine product line and further strengthen our market position in veterinary regenerative medicine.”

“ProVet APC has become the most highly sought-after regenerative system for equine athletes,” said Amy Hassinger, CEO Hassinger Biomedical. “We believe Dechra is specially poised, through their experience in the veterinary sector to meet the growing global demand by veterinarians and their clients for the ProVet APC and BMC Regenerative  Therapy Systems.”

This addition of the Provet APC products to Dechra's equine portfolio will complement our industry leading Orthokine® Vet irap joint therapy and provides veterinarians with a one stop partner for their regenerative medicine needs.

Read more here.

The post Dechra Acquires License For Two Equine Regenerative Therapy Systems appeared first on Horse Racing News | Paulick Report.

Source of original post

Study Finds Amniotic Extract Unhelpful To Speed Eye Healing In Horses

Equine eye injuries can be difficult to address and harder to heal – and they can be very painful for the horse. Any therapy that can be used to speed healing and decrease down time is welcomed by those who have had to administer eye meds to a horse.

A new experiment has shown that adding commercially available amniotic membrane to traditionally used antibiotics, antifungals, and pupil-dilating agents did not speed healing when compared with traditional medical treatments alone.

Drs. Victoria Lyons, Wendy Townsend, George Moore and Siqi Liang induced superficial corneal ulcers in both eyes of 10 healthy horses. One eye was treated with amniotic extract and the other eye was treated with the extract only to serve as the control. Both eyes were treated with topical therapies that included antifungal, antibiotics and drugs to dilate the pupil.

The ulcers were stained and photographed every 12 hours until they completely healed. Eyes treated with the amniotic fluid healed between 68.2 to 162.7 hours; eyes that used the control healed in 87.4 to 167.6 hours. No matter which therapy was used, the eyes healed in two distinct phases: a rapid initial phase and a slower second phase with a visible duration.

The researchers determined that adding a commercially available amniotic membrane extract to other topical medications did not significantly increase the rate of healing.

Read the article here.

Read more at EquiManagement.

The post Study Finds Amniotic Extract Unhelpful To Speed Eye Healing In Horses appeared first on Horse Racing News | Paulick Report.

Source of original post

Study: Does Light Therapy Assist With Wound Healing?

Different forms of light therapy have been touted to have many benefits for equine health, including assisting with healing soft tissue injuries and infections, as well as addressing sprains, strains, arthritis and swellings. But can it assist in healing wounds? 

Drs. Peter Michanek, Tamás Toth, Evelina Bergström, Helena Treffenberg‐Pettersson and Anna Bergh used eight Standardbreds to test the effects of pulsating visible red light and near infrared light on skin wounds. 

The research team made small, circular wounds on each side of the study horse's neck. The wound on one side was given one light treatment; the wound on the other side was left untreated. The light therapy was given by the same operator throughout the study and followed a standardized protocol: treatment was given five days a week for four weeks. 

Healing was monitored by someone who was unaware of which treatment, if any, the wounds had been given. The research team found little difference in the treated and control wounds in any phase of the study. The treated wounds took longer to completely heal than the untreated wounds.

The team concludes that in this study, pulsating visible red light and near infrared light do not speed healing of experimental skin wounds. 

Read the study here

Read more at Equine Science Update

The post Study: Does Light Therapy Assist With Wound Healing? appeared first on Horse Racing News | Paulick Report.

Source of original post

Verified by MonsterInsights